CONFLUX SYNTHESIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Oct 2025)
What this means for you
This application is over — abandoned 13 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90878963
- Mark type
- Stylized text
- Filed
- 12 Aug 2021
- Published for opposition
- 12 Jul 2022
- Abandoned
- 13 Oct 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: proteins for use in manufacture; proteins for industrial use in agriculture, aquaculture, cosmetics, consumer products and nutrition products
- Class 005 — Pharmaceuticals: protein arrays for medical diagnosis purposes; pharmaceutical preparations for use in the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders; therapeutic pharmaceuticals for the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders
- Class 042 — Scientific and technological services: scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products
Owner
- ABIOLOGICS, INC., CAMBRIDGE, MA, US
- Flagship Labs 83, Inc., Cambridge, MA, US
- Flagship Labs 83, Inc., Cambridge, MA, US
Prosecution history
- 13 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Apr 2025 — SOU EXTENSION 5 GRANTED
- 15 Jan 2025 — SOU EXTENSION 5 FILED
- 17 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 4 GRANTED
- 04 Sept 2024 — SOU EXTENSION 4 FILED
- 04 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2024 — SOU EXTENSION 3 GRANTED
- 04 Mar 2024 — SOU EXTENSION 3 FILED
- 04 Mar 2024 — SOU TEAS EXTENSION RECEIVED